Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 1, 2019
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
[ Fri, Nov 01st 2019
] - WOPRAI
Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $100 on, Nov 1st, 2019
Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $104 to $100 on, Nov 1st, 2019.
Matthew has made no other calls on BLUE in the last 4 months.
There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Benjamin Burnett of "Stifel" Initiated at Hold and Held Target at $109 on, Tuesday, October 1st, 2019
Similar Stocks and Investing Articles
[ Fri, Oct 11th 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Wed, Jan 23rd 2019
] - WOPRAI
[ Wed, Nov 28th 2018
] - WOPRAI
[ Thu, Nov 01st 2018
] - WOPRAI
[ Thu, Nov 01st 2018
] - WOPRAI
[ Fri, Oct 26th 2018
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Tue, Mar 01st 2016
] - WOPRAI
[ Wed, Feb 03rd 2016
] - WOPRAI